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Abstract corporeal membrane oxygenation. We present a case of near
Technological advances in extracorporeal membrane ox- fatal respiratory failure and hypercapnia in a 48-year-old 
ygenation and emerging evidence that it improves surviv- male in status asthmaticus not responsive to optimal ven­
al in adults with reversible respiratory failure compared to tilatory treatment. The use of veno-venous extracorporeal 
conventional ventilation has lead to increased utilization of membrane oxygenation resulted in full recovery with return 
extracorporeal membrane oxygenation in adults, usually in of normal respiratory function within nine days. 
the context of acute respiratory distress syndrome. Refracto- Keywords: acute respiratory failure, bronchial asthma, 
ry status asthmaticus is an uncommon indication for extra- extracorporeal membrane oxygenation.
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Introduction
Status asthmaticus is an acute exacerbation of asth­
ma that is unresponsive to repeated courses of beta-ago- 
nist therapy and is associated with signs or symptoms of 
potential respiratory failure. Mechanical ventilation for 
respiratory failure is currently the treatment of choice in 
severe cases of asthma, but is associated with increased 
in-hospital mortality compared with patients who do not 
require mechanical ventilation [1]. Ventilator strategies 
have been adopted to minimize complications such as 
barotrauma, dynamic hyperinflation and auto-positive 
end expiratory pressure but the new strategies have not 
eliminated these complications. In patients with venti­
lation-refractory hypercapnia and respiratory acidosis, 
extracorporeal membrane oxygenation (ECMO) may 
be an alternative ventilation strategy. Here we present 
our experience with veno-venous (V-V) ECMO for the 
treatment of hypercapneic respiratory failure in an adult 
male with severe refractory status asthmaticus.
Case Report
A 48-year-old man with past medical history signifi­
cant for Human Immunodeficiency Virus (CD4 266 and 
viral load 215) presented to the ED with increasing dys­
pnea over two days. He had a known history of severe 
persistent asthma with frequent exacerbations includ­
ing a recent admission requiring mechanical ventila­
tion for 8 days. He reported compliance with his regular 
antiviral and asthma medications.
RR -respiratory rate 
TV- tidal volume 
V-V - veno-venous
Upon presentation he was dyspneic and wheezing and 
tachycardic with heart rate of 104/min. He was not hypo­
tensive or tachypneic and had arterial oxygenation of 98% 
on room air. Chest x-ray demonstrated hyperinflation. He 
was initially treated with oxygen therapy via 2 liters nasal 
cannula, nebulized ipratropium bromide and albuterol, 
methylprednisolone 125 mg, magnesium sulfate 2 g, cef­
triaxone 1 g and azithromycin 500 mg. He was admitted 
to the hospital and maintained on nebulized ipratropium 
and albuterol q4 hours. On morning rounds patient was 
tachypneic with respiratory rate of 33/min and diffuse 
wheezing on exam with minimal air movement. His ipra­
tropium bromide and albuterol treatments were increased 
to q2 hours. His arterial oxygen saturation was 97% on 2L 
nasal cannula but repeat arterial blood gas demonstrated 
carbon dioxide retention: pH 7.31 pCO2 45 mmHg, pO2 84 
mmHg, HCO3- 22.7 mmol/L.
He was transferred to the MICU where he developed 
marked respiratory distress with accessory muscle use de­
spite use of 30% non-rebreather mask. He received anoth­
er dose of magnesium sulfate 2 mg and was started on he- 
liox gas. He continued to maintain oxygen saturation over 
90% but remained in respiratory distress with significant 
work of breathing. Oxygen therapy with non-invasive 
ventilator support via bipap at an inspiratory pressure of 
15 and expiratory pressure of 4 was initiated. However, 
he remained tachypneic, became increasingly fatigued 
and was found to have worsening respiratory acidosis: pH 
7.25, pCO2 54 mmHg, pO2 76 mmHg, HCO3- 23.7 mmol/L.
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The patient was intubated and started on assist con­
trol mode ventilation, with respiratory rate (RR) of 20, tid­
al volume (TV) of 460 ml, FiO2 40%, I:E ratio of 1:2.5, and 
positive end-expiratory pressure (PEEP) of 0 cm H2O. Ad­
junctive treatment with continuous nebulized ipratropi­
um bromide and albuterol, aminophylline (500 mg), cor­
ticosteroid (60 mg q 6hr), and magnesium sulfate (2 mg q 
6hr) were continued. Additionally, treatment with contin­
uous ketamine (1 mg/kg/hr) and the inhalation anesthetic 
agent isoflurane was initiated. His condition continued to 
deteriorate with worsening hypercapnia: pH 7.15, pCO2 85 
mmHg, pO2 115 mmHg, HCO3- 29.6 mmol/L.
Decision was made to initiate V-V ECMO for enhanced 
ventilation and carbon dioxide removal. This was performed 
on hospital day 6 via bi-femoral venous cannulation; right 
femoral to right atrium 25 cannula and left femoral cannula 
to inferior vena cava 23 cannula. Following the establish­
ment of ECMO his blood gasses quickly improved. Values at 
120 minutes after initiation of ECMO were: pH 7.33, pCO2 
40 mmHg, pO2 62 mmHg, HCO3- 21.1 mmol/L. Ventilation 
was maintained on conventional mechanical mode, with 
RR of 10, TV of 250 ml, FiO2 40%, and PEEP of 15 mmHg. 
Rate of ECMO sweep gas flow was initiated at 8 L/min and 
slowly decreased to 3 L/min over the next 5 days. He was 
on continuous nebulized albuterol and Solumedrol 60 mg 
q6 hours, which was tapered down every 3 days. V-V ECMO 
was discontinued after 9 days of support and patient was 
extubated within 24 hours of ECMO cessation. His hospital 
course was complicated by acute kidney injury which did 
not require renal replacement therapy. He was discharged 
initially to a skilled nursing facility and then to home.
At 9 month follow up patient was doing well. He re­
ported using his rescue inhaler 2-3 times per day and was 
tapering his prednisone from 20 mg/day to 10 mg/day.
Discussion
Patients with status asthmaticus who have progressive 
hypercapnia and or hypoxemia often require positive pres­
sure ventilation, but status asthmaticus patients are usu­
ally already hyperinflated and have extremely high levels 
of airway pressure, which increases their risk of ventilator
barotrauma and is associated with substantial mortality [2].
ECMO has traditionally been used in infants and chil­
dren with acute respiratory distress syndrome due to re­
versible pulmonary disease and as cardiac assistance in 
patients with circulatory failure [3]. In 1981, Kolobow 
published the first paper on extracorporeal carbon dioxide 
removal [4]. However, to date, ECMO is rarely used for the 
treatment of refractory status asthmaticus in adults. In a 
2009 retrospective cohort registry review of the interna­
tional Extracorporeal Life Support Organization Registry, 
among 1,257patients treated with ECMO, only 24 (2%) were 
asthmatics. Yet, survival to discharge was much higher for 
the asthmatic group (83%) as compared to non-asthmatics 
(50.8%), even after adjustment for confounders [5].
Presently there are no evidence-based guidelines 
for initiating ECMO for status asthmaticus. Much of 
the evidence in support of its use in status asthmaticus 
is based on case reports with the reported indications 
in this group ranging from cardiovascular compromise, 
cardiac arrest, hypoxemia and shock, severe hypercap­
nia and acidosis, to dynamic hyperinflation [2,6,7].
Based on the results of their own experience with 
hypercapneic respiratory failure in three patients in 
status asthmaticus, Kukita et al. suggested a simple al­
gorithm for initiation of ECMO: pH less than 7.2, PaCO2 
greater than 100 mm Hg, or life threatening conditions 
of hypoxemia, hypotension, or barotrauma in spite of 
optimization of ventilatory support [8]. Our patient fit 
these criteria. He had acute severe asthma, which did not 
improve despite maximum medical management and 
ventilator support. He continued to deteriorate and de­
veloped hypotension, hypercapnia and severe respirato­
ry acidosis but returned to normal respiratory function 
within nine days after initiation of ECMO.
Conclusion
Our case report illustrates the effective use of ECMO 
in the face of impending cardiorespiratory collapse in a 
patient with severe respiratory failure due to refractory 
status asthmaticus.
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